Greenleaf Peter

Director at PTHS; Chief Executive Officer at AUPH; CEO at Sucampo Pharmaceuticals, Inc.

Sold, on record
$7.4M
Dollars the filings state
Form 4 sales
7
Latest Jul 2, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Sucampo Pharmaceuticals, Inc.Unusual
    Nov 29 2016

    Sold 200,000 shares at $16.84 ($3.4M)

    Greenleaf Peter, CEO

    Sold 98.8% of holdings ($3.4M position)2,513 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AUPHPlan not stated
    Mar 2 +1919 days

    Sold 9,068 shares at $12.01 ($109k)

    Greenleaf Peter, Chief Executive Officer

    Sold 21.6% of holdings ($505k position)32,967 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale AUPHPlan not stated
    Mar 2 +365 days

    Sold 32,750 shares at $8.94 ($293k)

    Greenleaf Peter, Chief Executive Officer

    Sold 3.2% of holdings ($9.1M position)982,968 shares leftFiling

  4. 4 Form 4 sale AUPHNo plan
    Mar 6 +370 days

    Sold 126,981 shares at $5.60 ($711k)

    Greenleaf Peter, Chief Executive Officer

    No 10b5-1 planSold 7.7% of holdings ($9.2M position)1.5M shares leftFiling

  5. 5 Form 4 sale AUPHNo plan
    Mar 4 +363 days

    Sold 360,540 shares at $7.96 ($2.9M)

    Greenleaf Peter, Chief Executive Officer

    No 10b5-1 planSold 16.8% of holdings ($17.1M position)1.8M shares leftFiling

  6. 6 Form 4 sale PTHSRoutine
    Apr 2 +394 days

    Sold 797 shares at $20.92 ($17k)

    Greenleaf Peter, Director

    10b5-1 planSold 3.1% of holdings ($533k position)24,681 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale PTHSRoutine
    Jul 2 +91 days

    Sold 797 shares at $26.14 ($21k)

    Greenleaf Peter, Director

    10b5-1 planSold 3.2% of holdings ($645k position)23,884 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Greenleaf Peter
Source
Jul 2, 2026PTHSDirectorForm 4 sale797$21k3.2%RoutineSEC
Apr 2, 2026PTHSDirectorForm 4 sale797$17k3.1%RoutineSEC
Mar 4, 2025AUPHChief Executive OfficerForm 4 sale360,540$2.9M16.8%No planSEC
Mar 6, 2024AUPHChief Executive OfficerForm 4 sale126,981$711k7.7%No planSEC
Mar 2, 2023AUPHChief Executive OfficerForm 4 sale32,750$293k3.2%Plan not statedSEC
Mar 2, 2022AUPHChief Executive OfficerForm 4 sale9,068$109k21.6%Plan not statedSEC
Nov 29, 2016Sucampo Pharmaceuticals, Inc.CEOForm 4 sale200,000$3.4M98.8%UnusualSEC